Studies of Group Support and Survival Rates in Patients with Metastatic Breast Cancer
The Spiegel study's goal was to find if group therapy, for inpatients with metastatic breast cancer, had an impact on survival time. 86 patients with metastatic breast cancer were either assigned to group 1 or group 2 and evaluated in a randomized, controlled, 10-year follow up study.(1) Group 1 met weekly for 90 minutes for one year. Group 2, the control group did not meet at all.